<?xml version="1.0" ?><!--XBRL Document Created with Wdesk from Workiva--><!--Copyright 2021 Workiva--><!--r:0be097ba-d43c-4f44-889d-cacaccee3064,g:bf67277d-8752-4cc2-bdb2-57173a329d31,d:12a0e6d2de9140129042f58c5b8c89d5--><html xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns="http://www.w3.org/1999/xhtml" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2020-02-12" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:dei="http://xbrl.sec.gov/dei/2021" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:link="http://www.xbrl.org/2003/linkbase" xml:lang="en-US"><head><meta http-equiv="Content-Type" content="text/html"/>


<title>nh-20211112</title></head><body><div style="display:none"><ix:header><ix:hidden><ix:nonNumeric contextRef="i03040998e9ff4c17bfac218da578a715_D20211112-20211112" format="ixt:fixed-false" name="dei:AmendmentFlag" id="id3VybDovL2RvY3MudjEvZG9jOjEyYTBlNmQyZGU5MTQwMTI5MDQyZjU4YzViOGM4OWQ1L3NlYzoxMmEwZTZkMmRlOTE0MDEyOTA0MmY1OGM1YjhjODlkNV80L2ZyYWc6MDRhOTIyM2Y0NGRiNDAxZjhhZWFhMmE2NmNkMmViYTAvdGFibGU6Y2Y5ZDEyYzRmZWY3NGJhZmI5NDQ5ODgyYTZiMTZiNTQvdGFibGVyYW5nZTpjZjlkMTJjNGZlZjc0YmFmYjk0NDk4ODJhNmIxNmI1NF8wLTEtMS0xLTE5ODU1_b9b1f870-de47-4259-84e6-5ce7f64d2a67">FALSE</ix:nonNumeric><ix:nonNumeric contextRef="i03040998e9ff4c17bfac218da578a715_D20211112-20211112" name="dei:EntityCentralIndexKey" id="id3VybDovL2RvY3MudjEvZG9jOjEyYTBlNmQyZGU5MTQwMTI5MDQyZjU4YzViOGM4OWQ1L3NlYzoxMmEwZTZkMmRlOTE0MDEyOTA0MmY1OGM1YjhjODlkNV80L2ZyYWc6MDRhOTIyM2Y0NGRiNDAxZjhhZWFhMmE2NmNkMmViYTAvdGFibGU6Y2Y5ZDEyYzRmZWY3NGJhZmI5NDQ5ODgyYTZiMTZiNTQvdGFibGVyYW5nZTpjZjlkMTJjNGZlZjc0YmFmYjk0NDk4ODJhNmIxNmI1NF8xLTEtMS0xLTE5ODU1_0713830a-a019-41dc-9762-7230946b142c">0001566469</ix:nonNumeric></ix:hidden><ix:references xml:lang="en-US"><link:schemaRef xlink:type="simple" xlink:href="nh-20211112.xsd"></link:schemaRef></ix:references><ix:resources><xbrli:context id="i03040998e9ff4c17bfac218da578a715_D20211112-20211112"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001566469</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2021-11-12</xbrli:startDate><xbrli:endDate>2021-11-12</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia97ad6ba9ef74bae9a10f0450fec84cf_D20211112-20211112"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001566469</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:EntityAddressesAddressTypeAxis">dei:FormerAddressMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-11-12</xbrli:startDate><xbrli:endDate>2021-11-12</xbrli:endDate></xbrli:period></xbrli:context></ix:resources></ix:header></div><div id="i12a0e6d2de9140129042f58c5b8c89d5_1"></div><div style="min-height:31.5pt;width:100%"><div><span><br/></span></div></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:18pt;font-weight:700;line-height:120%">UNITED STATES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:18pt;font-weight:700;line-height:120%">SECURITIES AND EXCHANGE COMMISSION</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Washington, D.C. 20549</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:19.109%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"></td></tr></table></div><div style="margin-top:7pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:18pt;font-weight:700;line-height:120%">FORM <ix:nonNumeric contextRef="i03040998e9ff4c17bfac218da578a715_D20211112-20211112" name="dei:DocumentType" id="id3VybDovL2RvY3MudjEvZG9jOjEyYTBlNmQyZGU5MTQwMTI5MDQyZjU4YzViOGM4OWQ1L3NlYzoxMmEwZTZkMmRlOTE0MDEyOTA0MmY1OGM1YjhjODlkNV8xL2ZyYWc6ZDMyY2MwOGE5NGM1NGZlZmEwZGMxNjU3ZDU0NzYwNjAvdGV4dHJlZ2lvbjpkMzJjYzA4YTk0YzU0ZmVmYTBkYzE2NTdkNTQ3NjA2MF8xODIy_409ca1d1-fe5f-486e-856f-278b57e26388">8-K</ix:nonNumeric></span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:19.109%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"></td></tr></table></div><div style="margin-top:7pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:120%">CURRENT REPORT</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Pursuant to Section 13 OR 15(d) of</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:120%">the Securities Exchange Act of 1934</span></div><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">Date of Report (Date of earliest event reported)</span></div><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="i03040998e9ff4c17bfac218da578a715_D20211112-20211112" format="ixt:date-monthname-day-year-en" name="dei:DocumentPeriodEndDate" id="id3VybDovL2RvY3MudjEvZG9jOjEyYTBlNmQyZGU5MTQwMTI5MDQyZjU4YzViOGM4OWQ1L3NlYzoxMmEwZTZkMmRlOTE0MDEyOTA0MmY1OGM1YjhjODlkNV8xL2ZyYWc6ZDMyY2MwOGE5NGM1NGZlZmEwZGMxNjU3ZDU0NzYwNjAvdGV4dHJlZ2lvbjpkMzJjYzA4YTk0YzU0ZmVmYTBkYzE2NTdkNTQ3NjA2MF80OTQ3ODAyMzI2ODU1_d9f4d862-7f0c-47e4-9bcc-ec9272de3710">November 12, 2021</ix:nonNumeric> </span></div><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:18pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="i03040998e9ff4c17bfac218da578a715_D20211112-20211112" name="dei:EntityRegistrantName" id="id3VybDovL2RvY3MudjEvZG9jOjEyYTBlNmQyZGU5MTQwMTI5MDQyZjU4YzViOGM4OWQ1L3NlYzoxMmEwZTZkMmRlOTE0MDEyOTA0MmY1OGM1YjhjODlkNV8xL2ZyYWc6ZDMyY2MwOGE5NGM1NGZlZmEwZGMxNjU3ZDU0NzYwNjAvdGV4dHJlZ2lvbjpkMzJjYzA4YTk0YzU0ZmVmYTBkYzE2NTdkNTQ3NjA2MF8xODIz_867a537d-0c44-4c4f-9804-3e754ad61c5d">NantHealth, Inc.</ix:nonNumeric></span></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">(Exact name of registrant as specified in its charter)</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:90.804%"><tr><td style="width:1.0%"></td><td style="width:30.545%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.331%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:30.545%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.331%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:30.548%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%;text-decoration:underline"><ix:nonNumeric contextRef="i03040998e9ff4c17bfac218da578a715_D20211112-20211112" format="ixt-sec:stateprovnameen" name="dei:EntityIncorporationStateCountryCode" id="id3VybDovL2RvY3MudjEvZG9jOjEyYTBlNmQyZGU5MTQwMTI5MDQyZjU4YzViOGM4OWQ1L3NlYzoxMmEwZTZkMmRlOTE0MDEyOTA0MmY1OGM1YjhjODlkNV8xL2ZyYWc6ZDMyY2MwOGE5NGM1NGZlZmEwZGMxNjU3ZDU0NzYwNjAvdGFibGU6OTcxZmJiYjg3NmY0NGNkOGI1N2I2ZTQ0NjQyNDc3NDIvdGFibGVyYW5nZTo5NzFmYmJiODc2ZjQ0Y2Q4YjU3YjZlNDQ2NDI0Nzc0Ml8wLTAtMS0xLTE5ODU1_10fc1530-4a03-4564-9b94-c4ec83c2f074">Delaware</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%;text-decoration:underline"><ix:nonNumeric contextRef="i03040998e9ff4c17bfac218da578a715_D20211112-20211112" name="dei:EntityFileNumber" id="id3VybDovL2RvY3MudjEvZG9jOjEyYTBlNmQyZGU5MTQwMTI5MDQyZjU4YzViOGM4OWQ1L3NlYzoxMmEwZTZkMmRlOTE0MDEyOTA0MmY1OGM1YjhjODlkNV8xL2ZyYWc6ZDMyY2MwOGE5NGM1NGZlZmEwZGMxNjU3ZDU0NzYwNjAvdGFibGU6OTcxZmJiYjg3NmY0NGNkOGI1N2I2ZTQ0NjQyNDc3NDIvdGFibGVyYW5nZTo5NzFmYmJiODc2ZjQ0Y2Q4YjU3YjZlNDQ2NDI0Nzc0Ml8wLTItMS0xLTE5ODU1_9249a237-d82e-4e6a-9c31-79b6517330cb">001-37792</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%;text-decoration:underline"><ix:nonNumeric contextRef="i03040998e9ff4c17bfac218da578a715_D20211112-20211112" name="dei:EntityTaxIdentificationNumber" id="id3VybDovL2RvY3MudjEvZG9jOjEyYTBlNmQyZGU5MTQwMTI5MDQyZjU4YzViOGM4OWQ1L3NlYzoxMmEwZTZkMmRlOTE0MDEyOTA0MmY1OGM1YjhjODlkNV8xL2ZyYWc6ZDMyY2MwOGE5NGM1NGZlZmEwZGMxNjU3ZDU0NzYwNjAvdGFibGU6OTcxZmJiYjg3NmY0NGNkOGI1N2I2ZTQ0NjQyNDc3NDIvdGFibGVyYW5nZTo5NzFmYmJiODc2ZjQ0Y2Q4YjU3YjZlNDQ2NDI0Nzc0Ml8wLTQtMS0xLTE5ODU1_0f90c14d-5125-454f-9a43-795d2b017d13">27-3019889</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(State or other jurisdiction of <br/>incorporation)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(Commission File Number)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(IRS Employer<br/>Identification No.)</span></td></tr></table></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="i03040998e9ff4c17bfac218da578a715_D20211112-20211112" name="dei:EntityAddressAddressLine1" id="id3VybDovL2RvY3MudjEvZG9jOjEyYTBlNmQyZGU5MTQwMTI5MDQyZjU4YzViOGM4OWQ1L3NlYzoxMmEwZTZkMmRlOTE0MDEyOTA0MmY1OGM1YjhjODlkNV8xL2ZyYWc6ZDMyY2MwOGE5NGM1NGZlZmEwZGMxNjU3ZDU0NzYwNjAvdGV4dHJlZ2lvbjpkMzJjYzA4YTk0YzU0ZmVmYTBkYzE2NTdkNTQ3NjA2MF8xODMx_ed3366d6-7208-4c1a-8c6b-fd9b3528058d">3000 RDU Drive, Suite 200</ix:nonNumeric></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="i03040998e9ff4c17bfac218da578a715_D20211112-20211112" name="dei:EntityAddressCityOrTown" id="id3VybDovL2RvY3MudjEvZG9jOjEyYTBlNmQyZGU5MTQwMTI5MDQyZjU4YzViOGM4OWQ1L3NlYzoxMmEwZTZkMmRlOTE0MDEyOTA0MmY1OGM1YjhjODlkNV8xL2ZyYWc6ZDMyY2MwOGE5NGM1NGZlZmEwZGMxNjU3ZDU0NzYwNjAvdGV4dHJlZ2lvbjpkMzJjYzA4YTk0YzU0ZmVmYTBkYzE2NTdkNTQ3NjA2MF8xODE1_7a0e2999-c720-493c-8c03-94e12b62d437">Morrisville</ix:nonNumeric>, <ix:nonNumeric contextRef="i03040998e9ff4c17bfac218da578a715_D20211112-20211112" format="ixt-sec:stateprovnameen" name="dei:EntityAddressStateOrProvince" id="id3VybDovL2RvY3MudjEvZG9jOjEyYTBlNmQyZGU5MTQwMTI5MDQyZjU4YzViOGM4OWQ1L3NlYzoxMmEwZTZkMmRlOTE0MDEyOTA0MmY1OGM1YjhjODlkNV8xL2ZyYWc6ZDMyY2MwOGE5NGM1NGZlZmEwZGMxNjU3ZDU0NzYwNjAvdGV4dHJlZ2lvbjpkMzJjYzA4YTk0YzU0ZmVmYTBkYzE2NTdkNTQ3NjA2MF8xODMy_b7ec8a85-e7ff-4b69-9c05-28ed4f494435">North Carolina</ix:nonNumeric> <ix:nonNumeric contextRef="i03040998e9ff4c17bfac218da578a715_D20211112-20211112" name="dei:EntityAddressPostalZipCode" id="id3VybDovL2RvY3MudjEvZG9jOjEyYTBlNmQyZGU5MTQwMTI5MDQyZjU4YzViOGM4OWQ1L3NlYzoxMmEwZTZkMmRlOTE0MDEyOTA0MmY1OGM1YjhjODlkNV8xL2ZyYWc6ZDMyY2MwOGE5NGM1NGZlZmEwZGMxNjU3ZDU0NzYwNjAvdGV4dHJlZ2lvbjpkMzJjYzA4YTk0YzU0ZmVmYTBkYzE2NTdkNTQ3NjA2MF8xODI0_6a4d0c22-a5a1-4348-a997-c59556da610d">27560</ix:nonNumeric></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">(Address of principal executive offices) (Zip Code)</span></div><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">Registrant&#8217;s telephone number, including area code: </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%">(<ix:nonNumeric contextRef="i03040998e9ff4c17bfac218da578a715_D20211112-20211112" name="dei:CityAreaCode" id="id3VybDovL2RvY3MudjEvZG9jOjEyYTBlNmQyZGU5MTQwMTI5MDQyZjU4YzViOGM4OWQ1L3NlYzoxMmEwZTZkMmRlOTE0MDEyOTA0MmY1OGM1YjhjODlkNV8xL2ZyYWc6ZDMyY2MwOGE5NGM1NGZlZmEwZGMxNjU3ZDU0NzYwNjAvdGV4dHJlZ2lvbjpkMzJjYzA4YTk0YzU0ZmVmYTBkYzE2NTdkNTQ3NjA2MF8xODI1_7d7a046d-6ed9-4892-b52d-97169fdcbdd3">855</ix:nonNumeric>) <ix:nonNumeric contextRef="i03040998e9ff4c17bfac218da578a715_D20211112-20211112" name="dei:LocalPhoneNumber" id="id3VybDovL2RvY3MudjEvZG9jOjEyYTBlNmQyZGU5MTQwMTI5MDQyZjU4YzViOGM4OWQ1L3NlYzoxMmEwZTZkMmRlOTE0MDEyOTA0MmY1OGM1YjhjODlkNV8xL2ZyYWc6ZDMyY2MwOGE5NGM1NGZlZmEwZGMxNjU3ZDU0NzYwNjAvdGV4dHJlZ2lvbjpkMzJjYzA4YTk0YzU0ZmVmYTBkYzE2NTdkNTQ3NjA2MF8xODE2_b773dedb-4a51-4320-94cc-530d810da1fa">949-6268</ix:nonNumeric></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="ia97ad6ba9ef74bae9a10f0450fec84cf_D20211112-20211112" name="dei:EntityAddressAddressLine1" id="id3VybDovL2RvY3MudjEvZG9jOjEyYTBlNmQyZGU5MTQwMTI5MDQyZjU4YzViOGM4OWQ1L3NlYzoxMmEwZTZkMmRlOTE0MDEyOTA0MmY1OGM1YjhjODlkNV8xL2ZyYWc6ZDMyY2MwOGE5NGM1NGZlZmEwZGMxNjU3ZDU0NzYwNjAvdGV4dHJlZ2lvbjpkMzJjYzA4YTk0YzU0ZmVmYTBkYzE2NTdkNTQ3NjA2MF8xODE4_77e5b178-2d4a-423b-92d9-3e3f3329918f">9920 Jefferson Boulevard</ix:nonNumeric></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="ia97ad6ba9ef74bae9a10f0450fec84cf_D20211112-20211112" name="dei:EntityAddressCityOrTown" id="id3VybDovL2RvY3MudjEvZG9jOjEyYTBlNmQyZGU5MTQwMTI5MDQyZjU4YzViOGM4OWQ1L3NlYzoxMmEwZTZkMmRlOTE0MDEyOTA0MmY1OGM1YjhjODlkNV8xL2ZyYWc6ZDMyY2MwOGE5NGM1NGZlZmEwZGMxNjU3ZDU0NzYwNjAvdGV4dHJlZ2lvbjpkMzJjYzA4YTk0YzU0ZmVmYTBkYzE2NTdkNTQ3NjA2MF8xODI2_e166ec6f-5397-45ad-8277-b3b2ba9fef2b">Culver City</ix:nonNumeric>, <ix:nonNumeric contextRef="ia97ad6ba9ef74bae9a10f0450fec84cf_D20211112-20211112" format="ixt-sec:stateprovnameen" name="dei:EntityAddressStateOrProvince" id="id3VybDovL2RvY3MudjEvZG9jOjEyYTBlNmQyZGU5MTQwMTI5MDQyZjU4YzViOGM4OWQ1L3NlYzoxMmEwZTZkMmRlOTE0MDEyOTA0MmY1OGM1YjhjODlkNV8xL2ZyYWc6ZDMyY2MwOGE5NGM1NGZlZmEwZGMxNjU3ZDU0NzYwNjAvdGV4dHJlZ2lvbjpkMzJjYzA4YTk0YzU0ZmVmYTBkYzE2NTdkNTQ3NjA2MF8xODE5_b11c324d-7847-4d26-b52a-f6815d598057">California</ix:nonNumeric> <ix:nonNumeric contextRef="ia97ad6ba9ef74bae9a10f0450fec84cf_D20211112-20211112" name="dei:EntityAddressPostalZipCode" id="id3VybDovL2RvY3MudjEvZG9jOjEyYTBlNmQyZGU5MTQwMTI5MDQyZjU4YzViOGM4OWQ1L3NlYzoxMmEwZTZkMmRlOTE0MDEyOTA0MmY1OGM1YjhjODlkNV8xL2ZyYWc6ZDMyY2MwOGE5NGM1NGZlZmEwZGMxNjU3ZDU0NzYwNjAvdGV4dHJlZ2lvbjpkMzJjYzA4YTk0YzU0ZmVmYTBkYzE2NTdkNTQ3NjA2MF8xODI3_d1804f0a-2e9a-443c-b666-487c3741044a">90232</ix:nonNumeric></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">(Former name or former address, if changed since last report)</span></div><div style="margin-bottom:5pt;margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):</span></div><div style="margin-bottom:5pt;margin-top:12pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:11pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i03040998e9ff4c17bfac218da578a715_D20211112-20211112" format="ixt-sec:boolballotbox" name="dei:WrittenCommunications" id="id3VybDovL2RvY3MudjEvZG9jOjEyYTBlNmQyZGU5MTQwMTI5MDQyZjU4YzViOGM4OWQ1L3NlYzoxMmEwZTZkMmRlOTE0MDEyOTA0MmY1OGM1YjhjODlkNV8xL2ZyYWc6ZDMyY2MwOGE5NGM1NGZlZmEwZGMxNjU3ZDU0NzYwNjAvdGV4dHJlZ2lvbjpkMzJjYzA4YTk0YzU0ZmVmYTBkYzE2NTdkNTQ3NjA2MF8xODI4_c304fdbf-1888-4217-bbd7-6c0c6d1c7420">&#9744;</ix:nonNumeric></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%"> Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</span></div><div style="margin-bottom:5pt;margin-top:5pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:11pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i03040998e9ff4c17bfac218da578a715_D20211112-20211112" format="ixt-sec:boolballotbox" name="dei:SolicitingMaterial" id="id3VybDovL2RvY3MudjEvZG9jOjEyYTBlNmQyZGU5MTQwMTI5MDQyZjU4YzViOGM4OWQ1L3NlYzoxMmEwZTZkMmRlOTE0MDEyOTA0MmY1OGM1YjhjODlkNV8xL2ZyYWc6ZDMyY2MwOGE5NGM1NGZlZmEwZGMxNjU3ZDU0NzYwNjAvdGV4dHJlZ2lvbjpkMzJjYzA4YTk0YzU0ZmVmYTBkYzE2NTdkNTQ3NjA2MF8xODIx_3bc18e89-727c-42bc-9cef-c5217a4eee81">&#9744;</ix:nonNumeric></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%"> Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)</span></div><div style="margin-bottom:5pt;margin-top:5pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:11pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i03040998e9ff4c17bfac218da578a715_D20211112-20211112" format="ixt-sec:boolballotbox" name="dei:PreCommencementTenderOffer" id="id3VybDovL2RvY3MudjEvZG9jOjEyYTBlNmQyZGU5MTQwMTI5MDQyZjU4YzViOGM4OWQ1L3NlYzoxMmEwZTZkMmRlOTE0MDEyOTA0MmY1OGM1YjhjODlkNV8xL2ZyYWc6ZDMyY2MwOGE5NGM1NGZlZmEwZGMxNjU3ZDU0NzYwNjAvdGV4dHJlZ2lvbjpkMzJjYzA4YTk0YzU0ZmVmYTBkYzE2NTdkNTQ3NjA2MF8xODI5_0f12d39a-de03-4f95-ac7a-abde6f908ba3">&#9744;</ix:nonNumeric></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%"> Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))</span></div><div><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:11pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i03040998e9ff4c17bfac218da578a715_D20211112-20211112" format="ixt-sec:boolballotbox" name="dei:PreCommencementIssuerTenderOffer" id="id3VybDovL2RvY3MudjEvZG9jOjEyYTBlNmQyZGU5MTQwMTI5MDQyZjU4YzViOGM4OWQ1L3NlYzoxMmEwZTZkMmRlOTE0MDEyOTA0MmY1OGM1YjhjODlkNV8xL2ZyYWc6ZDMyY2MwOGE5NGM1NGZlZmEwZGMxNjU3ZDU0NzYwNjAvdGV4dHJlZ2lvbjpkMzJjYzA4YTk0YzU0ZmVmYTBkYzE2NTdkNTQ3NjA2MF8xODMw_6b700c49-6e92-47e8-be85-687666890a8b">&#9744;</ix:nonNumeric></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%"> Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))</span></div><div><span><br/></span></div><div style="padding-left:13.5pt;text-indent:-13.5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:36.831%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:23.037%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:36.832%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">Title of each class</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">Trading Symbol(s)</span></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">Name of each exchange on which registered</span></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i03040998e9ff4c17bfac218da578a715_D20211112-20211112" name="dei:Security12bTitle" id="id3VybDovL2RvY3MudjEvZG9jOjEyYTBlNmQyZGU5MTQwMTI5MDQyZjU4YzViOGM4OWQ1L3NlYzoxMmEwZTZkMmRlOTE0MDEyOTA0MmY1OGM1YjhjODlkNV8xL2ZyYWc6ZDMyY2MwOGE5NGM1NGZlZmEwZGMxNjU3ZDU0NzYwNjAvdGFibGU6YjM1MWZiY2YxODRhNGQ3OGFjOGExMDQwMzQ2OWE3NzEvdGFibGVyYW5nZTpiMzUxZmJjZjE4NGE0ZDc4YWM4YTEwNDAzNDY5YTc3MV8xLTAtMS0xLTE5ODU1_ad864fc2-473c-48ff-b19e-9e5fa551e7b1">Common Stock, par value $0.0001 per share</ix:nonNumeric></span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i03040998e9ff4c17bfac218da578a715_D20211112-20211112" name="dei:TradingSymbol" id="id3VybDovL2RvY3MudjEvZG9jOjEyYTBlNmQyZGU5MTQwMTI5MDQyZjU4YzViOGM4OWQ1L3NlYzoxMmEwZTZkMmRlOTE0MDEyOTA0MmY1OGM1YjhjODlkNV8xL2ZyYWc6ZDMyY2MwOGE5NGM1NGZlZmEwZGMxNjU3ZDU0NzYwNjAvdGFibGU6YjM1MWZiY2YxODRhNGQ3OGFjOGExMDQwMzQ2OWE3NzEvdGFibGVyYW5nZTpiMzUxZmJjZjE4NGE0ZDc4YWM4YTEwNDAzNDY5YTc3MV8xLTEtMS0xLTE5ODU1_15dd1a27-d545-40cb-8d27-027306d91c1d">NH</ix:nonNumeric></span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 4.37pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i03040998e9ff4c17bfac218da578a715_D20211112-20211112" format="ixt-sec:exchnameen" name="dei:SecurityExchangeName" id="id3VybDovL2RvY3MudjEvZG9jOjEyYTBlNmQyZGU5MTQwMTI5MDQyZjU4YzViOGM4OWQ1L3NlYzoxMmEwZTZkMmRlOTE0MDEyOTA0MmY1OGM1YjhjODlkNV8xL2ZyYWc6ZDMyY2MwOGE5NGM1NGZlZmEwZGMxNjU3ZDU0NzYwNjAvdGFibGU6YjM1MWZiY2YxODRhNGQ3OGFjOGExMDQwMzQ2OWE3NzEvdGFibGVyYW5nZTpiMzUxZmJjZjE4NGE0ZDc4YWM4YTEwNDAzNDY5YTc3MV8xLTItMS0xLTE5ODU1_84ee7716-eef3-4cec-acd4-5449e3ccf18d">Nasdaq Stock Market LLC</ix:nonNumeric></span></td></tr></table></div><div><span><br/></span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (17 CFR &#167;(&#167;230.405) or Rule 12b-2 of the Securities Exchange Act of 1934 (17 CFR &#167;(&#167;240.12b-2).                                                                                                          </span></div><div style="text-indent:18pt"><span><br/></span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Emerging growth company </span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:11pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i03040998e9ff4c17bfac218da578a715_D20211112-20211112" format="ixt:fixed-true" name="dei:EntityEmergingGrowthCompany" id="id3VybDovL2RvY3MudjEvZG9jOjEyYTBlNmQyZGU5MTQwMTI5MDQyZjU4YzViOGM4OWQ1L3NlYzoxMmEwZTZkMmRlOTE0MDEyOTA0MmY1OGM1YjhjODlkNV8xL2ZyYWc6ZDMyY2MwOGE5NGM1NGZlZmEwZGMxNjU3ZDU0NzYwNjAvdGV4dHJlZ2lvbjpkMzJjYzA4YTk0YzU0ZmVmYTBkYzE2NTdkNTQ3NjA2MF8xODIw_eff95da1-8cfd-49b4-91a8-ea07af502dba">&#9746;</ix:nonNumeric></span></div><div style="text-indent:18pt"><span><br/></span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If an emerging growth company, indicate by check mark if the Registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.&#160; </span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:11pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i03040998e9ff4c17bfac218da578a715_D20211112-20211112" format="ixt:fixed-true" name="dei:EntityExTransitionPeriod" id="id3VybDovL2RvY3MudjEvZG9jOjEyYTBlNmQyZGU5MTQwMTI5MDQyZjU4YzViOGM4OWQ1L3NlYzoxMmEwZTZkMmRlOTE0MDEyOTA0MmY1OGM1YjhjODlkNV8xL2ZyYWc6ZDMyY2MwOGE5NGM1NGZlZmEwZGMxNjU3ZDU0NzYwNjAvdGV4dHJlZ2lvbjpkMzJjYzA4YTk0YzU0ZmVmYTBkYzE2NTdkNTQ3NjA2MF8xODMz_d0d37f96-1839-4301-aeb8-0a146674ab95">&#9746;</ix:nonNumeric></span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr></table></div><div style="height:31.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div></div></div><div id="i12a0e6d2de9140129042f58c5b8c89d5_7"></div><hr style="page-break-after:always"/><div style="min-height:18pt;width:100%"><div><span><br/></span></div></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:10.776%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:87.024%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Item&#160;1.01</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%;text-decoration:underline">Entry into a Material Definitive Agreement</span></td></tr></table></div><div style="text-align:justify"><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9.5pt;font-weight:400;line-height:112%">On November 12, 2021, NantHealth, Inc. (the &#8220;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9.5pt;font-style:italic;font-weight:700;line-height:112%">Company</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9.5pt;font-weight:400;line-height:112%">&#8221;) entered into an Open Market Sale Agreement (the &#8220;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9.5pt;font-style:italic;font-weight:700;line-height:112%">Sale Agreement</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9.5pt;font-weight:400;line-height:112%">&#8221;) with Jefferies LLC (the &#8220;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9.5pt;font-style:italic;font-weight:700;line-height:112%">Sales Agent</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9.5pt;font-weight:400;line-height:112%">&#8221;) under which it may offer and sell up to $30,000,000 of shares of its common stock, par value $0.0001 per share (the &#8220;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9.5pt;font-style:italic;font-weight:700;line-height:112%">Shares</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9.5pt;font-weight:400;line-height:112%">&#8221;), from time to time through the Sales Agent.  The sales and issuances of the Shares under the Sale Agreement will be made pursuant to the Company&#8217;s effective shelf registration statement on Form S-3 (the &#8220;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9.5pt;font-style:italic;font-weight:700;line-height:112%">Registration Statement</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9.5pt;font-weight:400;line-height:112%">&#8221;)</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9.5pt;font-weight:400;line-height:112%"> </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9.5pt;font-weight:400;line-height:112%">that was declared effective on May 6, 2021.  The offering is described in the Company&#8217;s Prospectus, as supplemented by a Prospectus Supplement dated November 12, 2021, as filed with the U.S. Securities and Exchange Commission (the &#8220;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9.5pt;font-style:italic;font-weight:700;line-height:112%">SEC</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9.5pt;font-weight:400;line-height:112%">&#8221;) on November 12, 2021 (together, the &#8220;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9.5pt;font-style:italic;font-weight:700;line-height:112%">Prospectus</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9.5pt;font-weight:400;line-height:112%">&#8221;).</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9.5pt;font-weight:400;line-height:112%">Pursuant to the Sale Agreement, sales, if any, of the Shares, will be made under the Prospectus, by any method permitted by law deemed to be an &#8220;at the market offering&#8221; as defined in Rule 415(a)(4) under the Securities Act of 1933, as amended (the &#8220;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9.5pt;font-style:italic;font-weight:700;line-height:112%">Securities Act</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9.5pt;font-weight:400;line-height:112%">&#8221;), including block transactions, sales made directly on the Nasdaq Global Select Market or sales made into any other existing trading market for the registrant&#8217;s common stock. The Sales Agent is not required to sell any specific amount of securities, but will act as our sales agent using commercially reasonable efforts to sell the Shares from time to time, consistent with their normal trading and sales practices, applicable state and federal laws, rules and regulations and the rules of The Nasdaq Global Select Market, based upon instructions from the Company (including any price, time or size limits or other customary parameters or conditions the Company may impose). The Company has agreed to pay the Sales Agent a commission of 3.0% of the aggregate gross proceeds from each sale of Shares pursuant to the Sale Agreement and to provide the Sales Agent with customary indemnification and contribution rights, including for liabilities under the Securities Act.  The Sales Agent&#8217;s obligations to sell the Shares under the Sale Agreement are subject to satisfaction of certain conditions, including customary closing conditions.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">The Company is not obligated to sell any Shares under the Sale Agreement and may at any time suspend solicitation and offers under the Sale Agreement. The Sale Agreement may be terminated by either party as set forth in the Sale Agreement. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">The foregoing description of the Sale Agreement is not complete and is qualified in its entirety by reference to the full text of the Sale Agreement, a copy of which is filed herewith as Exhibit 10.1 to this Current Report on Form 8-K and is incorporated herein by reference.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">This Current Report on Form 8-K shall not constitute an offer to sell or the solicitation of an offer to buy the securities discussed herein, nor shall there be any offer, solicitation, or sale of the securities in any state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">Wilson Sonsini Goodrich &amp; Rosati, Professional Corporation, counsel to the Company, has issued a legal opinion relating to the validity of the Shares being offered pursuant to the Sale Agreement. A copy of such legal opinion, including the consent included therein, is filed as Exhibit 5.1 to this Current Report on Form 8-K and is incorporated herein by reference.</span></div><div style="margin-top:2pt;text-indent:18pt"><span><br/></span></div><div id="i12a0e6d2de9140129042f58c5b8c89d5_10"></div><div style="-sec-extract:summary"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:89.105%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Item&#160;9.01</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%;text-decoration:underline">Financial Statements and Exhibits</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">.</span></div></td></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">(d) Exhibits.</span></div><div style="text-align:justify"><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:12.496%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:85.304%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%;text-decoration:underline">Exhibit&#160;No.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%;text-decoration:underline">Description</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">5.1</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%;text-decoration:underline" href="exhibit51opinionofwilsonso.htm">Opinion of Wilson Sonsini Goodrich &amp; Rosati, P.C.</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">10.1</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9.5pt;font-weight:400;line-height:112%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:9.5pt;font-weight:400;line-height:112%;text-decoration:underline" href="exhibit101openmarketsaleag.htm">Open Market Sale Agreement</a></span><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:6.17pt;font-weight:400;line-height:112%;position:relative;text-decoration:underline;top:-3.32pt;vertical-align:baseline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:6.17pt;font-weight:400;line-height:112%;position:relative;text-decoration:underline;top:-3.32pt;vertical-align:baseline" href="exhibit101openmarketsaleag.htm">SM</a></span><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9.5pt;font-weight:400;line-height:112%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:9.5pt;font-weight:400;line-height:112%;text-decoration:underline" href="exhibit101openmarketsaleag.htm"> dated November 12, 2021, by and between NantHealth, Inc.</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:9.5pt;font-weight:400;line-height:112%;text-decoration:underline" href="exhibit101openmarketsaleag.htm"> and Jefferies LLC</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">23.1#</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9.5pt;font-weight:400;line-height:112%">Consent of Wilson Sonsini Goodrich &amp; Rosati, P.C. (included in Exhibit 5.1).</span></div></td></tr></table></div><div style="padding-left:18pt;text-indent:-18pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"># Filed herewith.</span></div><div style="height:18pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div></div></div><div id="i12a0e6d2de9140129042f58c5b8c89d5_13"></div><hr style="page-break-after:always"/><div style="min-height:18pt;width:100%"><div><span><br/></span></div></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%">SIGNATURE</span></div><div style="margin-top:12pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.</span></div><div style="margin-top:12pt;text-indent:24.75pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:4.747%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:49.338%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.578%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:37.937%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">NantHealth, Inc.</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Date:</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">November 12, 2021</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">By:</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">/s/ Bob Petrou</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Bob Petrou</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Chief Financial Officer</span></td></tr></table></div><div style="height:18pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div></div></div></body></html>
[{"type": "8-K", "sequence": "1", "filename": "nh-20211112.htm", "description": "8-K", "secsgml_size_bytes": 44158}]
{"company-data": {"conformed-name": "NantHealth, Inc.", "cik": "0001566469", "assigned-sic": "7374", "irs-number": "273019889", "state-of-incorporation": "DE", "fiscal-year-end": "1231"}, "filing-values": {"form-type": "8-K", "act": "34", "file-number": "001-37792", "film-number": "211405020"}, "business-address": {"street1": "9920 JEFFERSON BLVD", "city": "CULVER CITY", "state": "CA", "zip": "90232", "phone": "(310) 853-7513"}, "mail-address": {"street1": "9920 JEFFERSON BLVD", "city": "CULVER CITY", "state": "CA", "zip": "90232"}, "former-company": {"former-conformed-name": "Nant Health, LLC", "date-changed": "20130108"}}
nh-20211112
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM
8-K
CURRENT REPORT
Pursuant to Section 13 OR 15(d) of
the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported)
November 12, 2021
NantHealth, Inc.
(Exact name of registrant as specified in its charter)
Delaware
001-37792
27-3019889
(State or other jurisdiction of
incorporation)
(Commission File Number)
(IRS Employer
Identification No.)
3000 RDU Drive, Suite 200
Morrisville
,
North Carolina
27560
(Address of principal executive offices) (Zip Code)
Registrant's telephone number, including area code:
(
855
)
949-6268
9920 Jefferson Boulevard
Culver City
,
California
90232
(Former name or former address, if changed since last report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
☐
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
☐
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
☐
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Title of each class
Trading Symbol(s)
Name of each exchange on which registered
Common Stock, par value $0.0001 per share
NH
Nasdaq Stock Market LLC
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (17 CFR §(§230.405) or Rule 12b-2 of the Securities Exchange Act of 1934 (17 CFR §(§240.12b-2).
Emerging growth company
☒
If an emerging growth company, indicate by check mark if the Registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.
☒
Item 1.01
Entry into a Material Definitive Agreement
On November 12, 2021, NantHealth, Inc. (the "
Company
") entered into an Open Market Sale Agreement (the "
Sale Agreement
") with Jefferies LLC (the "
Sales Agent
") under which it may offer and sell up to $30,000,000 of shares of its common stock, par value $0.0001 per share (the "
Shares
"), from time to time through the Sales Agent.  The sales and issuances of the Shares under the Sale Agreement will be made pursuant to the Company's effective shelf registration statement on Form S-3 (the "
Registration Statement
")
that was declared effective on May 6, 2021.  The offering is described in the Company's Prospectus, as supplemented by a Prospectus Supplement dated November 12, 2021, as filed with the U.S. Securities and Exchange Commission (the "
SEC
") on November 12, 2021 (together, the "
Prospectus
").
Pursuant to the Sale Agreement, sales, if any, of the Shares, will be made under the Prospectus, by any method permitted by law deemed to be an "at the market offering" as defined in Rule 415(a)(4) under the Securities Act of 1933, as amended (the "
Securities Act
"), including block transactions, sales made directly on the Nasdaq Global Select Market or sales made into any other existing trading market for the registrant's common stock. The Sales Agent is not required to sell any specific amount of securities, but will act as our sales agent using commercially reasonable efforts to sell the Shares from time to time, consistent with their normal trading and sales practices, applicable state and federal laws, rules and regulations and the rules of The Nasdaq Global Select Market, based upon instructions from the Company (including any price, time or size limits or other customary parameters or conditions the Company may impose). The Company has agreed to pay the Sales Agent a commission of 3.0% of the aggregate gross proceeds from each sale of Shares pursuant to the Sale Agreement and to provide the Sales Agent with customary indemnification and contribution rights, including for liabilities under the Securities Act.  The Sales Agent's obligations to sell the Shares under the Sale Agreement are subject to satisfaction of certain conditions, including customary closing conditions.
The Company is not obligated to sell any Shares under the Sale Agreement and may at any time suspend solicitation and offers under the Sale Agreement. The Sale Agreement may be terminated by either party as set forth in the Sale Agreement.
The foregoing description of the Sale Agreement is not complete and is qualified in its entirety by reference to the full text of the Sale Agreement, a copy of which is filed herewith as Exhibit 10.1 to this Current Report on Form 8-K and is incorporated herein by reference.
This Current Report on Form 8-K shall not constitute an offer to sell or the solicitation of an offer to buy the securities discussed herein, nor shall there be any offer, solicitation, or sale of the securities in any state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction.
Wilson Sonsini Goodrich & Rosati, Professional Corporation, counsel to the Company, has issued a legal opinion relating to the validity of the Shares being offered pursuant to the Sale Agreement. A copy of such legal opinion, including the consent included therein, is filed as Exhibit 5.1 to this Current Report on Form 8-K and is incorporated herein by reference.
Item 9.01
Financial Statements and Exhibits
.
(d) Exhibits.
Exhibit No.
Description
5.1
Opinion of Wilson Sonsini Goodrich & Rosati, P.C.
10.1
Open Market Sale Agreement
SM
dated November 12, 2021, by and between NantHealth, Inc.
and Jefferies LLC
23.1#
Consent of Wilson Sonsini Goodrich & Rosati, P.C. (included in Exhibit 5.1).
# Filed herewith.
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
NantHealth, Inc.
Date:
November 12, 2021
By:
/s/ Bob Petrou
Bob Petrou
Chief Financial Officer